as on February 4, 2026 at 10:37 pm IST
Day's Low
Day's High
0.85%
Downside
1.69%
Upside
52 Week's Low
52 Week's High
6.77%
Downside
991.53%
Upside
Check Pliant Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$79.3M
EPS (TTM)
-2.4468
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-4.69
Industry PE ratio
-1.9307053941908714
PEG Ratio
0EBITDA
-188.1M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-64.27%
Track how Pliant Therapeutics Inc P/E has moved over time to understand its valuation trends.
Pliant Therapeutics Inc in the last 5 years
Lowest (-13.59x)
June 30, 2021
Today (-4.69x)
February 4, 2026
Industry (-1.93x)
February 4, 2026
Highest (-0.42x)
June 30, 2025
Today’s Price to Earnings Ratio: -4.69x
Compare market cap, revenue, PE, and other key metrics of Pliant Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $79.3M | -96.14% | -4.69 | 0.00% | |
| BUY | $122.3B | 117.87% | 33.56 | 31.35% | |
| BUY | $47.7B | 122.79% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 52.19% | 18.28 | 32.13% |
The Pliant Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Pliant Therapeutics Inc investment value today
Current value as on today
₹14,252
Returns
Returns from Pliant Therapeutics Inc Stock
Dollar Returns*
₹3,873 (+3.87%)
Based on 20 analysts
95.00%
Buy
5.00%
Hold
0.00%
Sell
Based on 20 analysts, 95% of analysts recommend a 'BUY' rating for Pliant Therapeutics Inc. Average target price of $3.25
Get share price movements and forecasts by analysts on Pliant Therapeutics Inc.
What analysts predicted
63.69%UPSIDE
Target Price
$3.25
Current Price
$1.18
Analyzed by
20 Analysts
Target
$3.25
Pliant Therapeutics Inc target price $3.25, a slight upside of 63.69% compared to current price of $1.18. According to 20 analysts rating.
Search interest for Pliant Therapeutics Inc Stock has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -56.16M → -26.30M (in $), with an average increase of 47.2% per quarter
Against Peers
![]()
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 34.8% return, outperforming this stock by 131.2%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 55.4% return, outperforming this stock by 144.8%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 4.83M → 2.27M (in $), with an average decrease of 53.1% per quarter
Price Dip
![]()
In the last 1 year, PLRX stock has moved down by -89.4%
| Organisation | Pliant Therapeutics Inc |
| Headquarters | 331 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
| Industry | Health Technology |
| CEO | Dr. Bernard Coulie M.B.A., M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Bernard Coulie M.B.A., M.D., Ph.D. | President, CEO & Director |
Dr. Keith Lamont Cummings M.B.A., M.D. | Chief Financial Officer |
Dr. Rik Derynck Ph.D. | Scientific Founder & Member of Scientific Advisory Board |
Monica Sandberg Ph.D. | Vice President, Regulatory & Compliance |
Ms. Lily Cheung | Chief Human Resources Officer |
Mr. Dean Sheppard M.D. | Scientific Founder & Member of Scientific Advisory Board |
Mr. Hal Chapman M.D. | Scientific Founder & Member of Scientific Advisory Board |
Ms. Minnie Kuo | Chief Operating Officer |
Ms. Delphine Imbert Ph.D. | Chief Technical Officer |
Mr. Christopher S. Keenan | Vice President of Investor Relations & Corporate Communications |
Pliant Therapeutics Inc share price today is $1.18 as on . Pliant Therapeutics Inc share today touched a day high of $1.2 and a low of $1.17.
Pliant Therapeutics Inc share touched a 52 week high of $12.88 on and a 52 week low of $1.1 on . Pliant Therapeutics Inc stock price today i.e. is trending at $1.18,which is 90.84% down from its 52 week high and 7.26% up from its 52 week low.
Pliant Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Pliant Therapeutics Inc (PLRX) shares with as little as ₹90.453 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹904.53 in Pliant Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Pliant Therapeutics Inc share’s latest price of $1.18 as on February 4, 2026 at 10:37 pm IST, you will get 8.4746 shares of Pliant Therapeutics Inc. Learn more about
fractional shares .
Pliant Therapeutics Inc stock has given -96.14% share price returns and 25.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?